The presence of intraductal carcinoma of prostate is a risk factor for poor pathologic response in men with high-risk prostate cancer receiving neoadjuvant therapy

被引：0
|
作者：
Binyu, W. [1 ]
Yao, F. [2 ]
Mengxia, C. [1 ]
Shan, P. [2 ]
Giancarlo, M. [3 ]
Junlong, Z. [1 ]
Shiwei, Z. [1 ]
Hongqian, G. [1 ]
Xuefeng, Q. [1 ]
机构：
[1] Nanjing Univ, Sch Med, Affiliated Nanjing Drum Tower Hosp, Dept Urol, Nanjing, Peoples R China
[2] Nanjing Univ, Sch Med, Affiliated Nanjing Drum Tower Hosp, Dept Pathol, Nanjing, Peoples R China
[3] San Giovanni Battista Hosp, Dept Urol, Turin, Italy
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0290
引用
收藏
页码：S1084 / S1084
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant and adjuvant chemotherapy for high-risk localized prostate cancer
    Nakabayashi M.
    Oh W.K.
    Current Treatment Options in Oncology, 2004, 5 (5) : 349 - 355
  • [22] Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer
    Garzotto, M
    Myrthue, A
    Higano, CS
    Beer, TM
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (03) : 254 - 259
  • [23] Eighteen Months of Androgen Deprivation Therapy in Men with High-risk Prostate Cancer and the Risk of Death
    Xie, Wanling
    D'Amico, Anthony V.
    EUROPEAN UROLOGY, 2018, 74 (04) : 442 - 443
  • [24] Diabetes and the risk of death in men with favorable or high-risk prostate cancer following radiation therapy
    D'Amico, A. V.
    Braccioforte, M. H.
    Moran, B. J.
    Chen, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer
    John Thoms
    Jayant S. Goda
    Alexender R. Zlotta
    Neil E. Fleshner
    Theodorus H. van der Kwast
    Stéphane Supiot
    Padraig Warde
    Robert G. Bristow
    Nature Reviews Clinical Oncology, 2011, 8 : 107 - 113
  • [26] Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer
    Thoms, John
    Goda, Jayant S.
    Zlotta, Alexendre R.
    Fleshner, Neil E.
    van der Kwast, Theodorus H.
    Supiot, St Phane
    Warde, Padraig
    Bristow, Robert G.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (02) : 107 - 113
  • [27] Prostate Cancer-Specific Mortality and the Extent of Therapy in Healthy Elderly Men With High-Risk Prostate Cancer
    Hoffman, Karen E.
    Chen, Ming-Hui
    Moran, Brian J.
    Braccioforte, Michelle H.
    Dosoretz, Daniel
    Salenius, Sharon
    Katin, Michael J.
    Ross, Rudi
    D'Amico, Anthony V.
    CANCER, 2010, 116 (11) : 2590 - 2595
  • [28] High-risk prostate cancer: treat the prostate
    Cooperberg, Matthew R.
    LANCET, 2011, 378 (9809): : 2056 - 2057
  • [29] Current role of neoadjuvant and adjuvant systemic therapy for high-risk localized prostate cancer
    Dorff, Tanya B.
    Glode, L. Michael
    CURRENT OPINION IN UROLOGY, 2013, 23 (04) : 366 - 371
  • [30] Tissue biomarkers in patients with high-risk prostate cancer treated with neoadjuvant chemohormonal therapy
    Narita, Shintaro
    Nara, Taketoshi
    Chiba, Syuji
    Kanda, Sohei
    Numakura, Kazuyuki
    Saito, Mitsuru
    Inoue, Takamitsu
    Huang, Mingguo
    Nanjo, Hiroshi
    Habuchi, Tomonori
    CANCER SCIENCE, 2018, 109 : 1023 - 1023
12345